ArticleAlimentary pharmacology & therapeutics2022

Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean?

Eamonn M M QuigleyPubMed ↗Publisher ↗

No numbers read from the abstract.